Analysis of coagulation during ECMO
- Conditions
- J80Adult respiratory distress syndrome
- Registration Number
- DRKS00005650
- Lead Sponsor
- niversitätsmedizin Göttingen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Newly installed ECMO
Exclusion Criteria
ARDS not indicated for ECMO therapy,
ECMO for other indications than ARDS
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method During ECMO the course of coagulation function will be monitored<br><br>Anlysis includes general amrkers (Quick, aPTT, Fibrinogen, Thrombozyt count, AT-III, Xa-Activity, D-Dimers, ACT)<br>and activity of coagulation factors (II, V, VII, VIII, IX, X, XII, XIII, vWF-antigen and activity) <br>
- Secondary Outcome Measures
Name Time Method